News RSS Bioethics News.

01/18/2018

First treatment approved for breast cancer with BRCA genetic mutation

External Link - Source: Washington Post

The Food and Drug Administration on Friday cleared the first treatment for patients with advanced breast cancer caused by BRCA mutations, which are genetic defects that raise the risk of malignancies.

This entry was posted in Clinical Ethics and tagged . Bookmark the permalink.